BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04035486-completion@plaintrial.com
DTSTAMP:20261029T091353Z
DTSTART;VALUE=DATE:20261222
SUMMARY:A Study of Osimertinib With or Without Chemotherapy as 1st Line Tre
 atment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small
  Cell Lung Cancer (FLAURA2) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04035486
URL:https://plaintrial.com/trial/NCT04035486
END:VEVENT
END:VCALENDAR